MUC17 and glioblastoma: MUC17 has also been reported on and, although not explicitly identified in the Human Protein Atlas as a candidate based on single-cell fractional expression data, it was nonetheless found associated with poor prognosis in both non-GBM and GBM cohorts [55,57,67].